Updates from FDA
In March of this year, FDA approved the first and only calcitonin gene–related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults.
Lauren Howell, PharmD
Although sun exposure has been known to have damaging effects on skin since ancient times when Egyptians used mixtures thought to prevent sunburn, it wasn’t until the late 1800s that the negative health effects of prolonged exposure to UV rays were scientifically confirmed.
Mary Warner
On March 6, 2023, FDA released its Dietary Supplement Ingredient Directory, a new way for consumers, manufacturers, and retailers to quickly locate information about products and ingredients marketed as dietary supplements.
Mickie Cathers
When the latest drugs to treat Alzheimer disease are expensive, hard to get, and backed with little evidence, how do pharmacists and other clinicians help patients?